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by real-time PCR and culture, indicating asymp-
tomatic carriage of toxinogenic C. difﬁcile [11,12].
These three samples were conﬁrmed as positive
following re-extraction and re-testing by real-time
PCR.
For further clinical evaluation, 85 faecal samples
received from adult patients with a request for
C. difﬁcile testing or from patients with diarrhoea
admitted to the hospital for ‡3 days were investi-
gated prospectively (Table 2). These samples were
tested initially by ELFA, and were then stored at
) 80C within 24 h pending further analysis by the
cell cytotoxicity assay and real-time PCR. Of six
(7%) samples positive by the cell cytotoxicity assay
(Table 2), ﬁve were positive by ELFA, and six by
real-time PCR. Of 79 cytotoxicity-negative sam-
ples, one was positive by ELFA and real-time PCR,
andﬁvewere positive only by real-timePCR. Thus,
11 (13%) of 85 samples were positive by real-time
PCR;C. difﬁcilewas cultured subsequently from all
these samples. Using the cytotoxicity assay as the
standard, the sensitivity, speciﬁcity and PPV and
NPV for the real-time PCR assay were 100%, 94%,
55% and 100%, respectively.
In conclusion, detection of the C. difﬁcile tcdB
gene in faecal samples by real-time PCR, using an
automated DNA extraction protocol and an inter-
nal control, can be used as a rapid method for
diagnosing CDAD and for detecting carriage in
asymptomatic patients.
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ABSTRACT
This study investigated the prevalence of methi-
cillin-resistant Staphylococcus aureus (MRSA) in
infected and uninfected diabetic foot ulcers of 84
patients with the two types of diabetes. S. aureus
was the most common pathogen among the
Gram-positive bacteria isolated from ulcers, and
almost 50% of S. aureus isolates were MRSA. The
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prevalence of MRSA was signiﬁcantly higher in
patients with infected foot ulcers. MRSA infection
or colonisation was not associated with factors
(previous hospitalisation, use of antibiotics, etc.)
known to predispose to MRSA colonisation or
infection. The high prevalence of MRSA in
patients with foot ulcers may reﬂect the increased
prevalence of MRSA in the community.
Keywords Diabetes, foot ulcers, infection, methicillin
resistance, MRSA, Staphylococcus aureus
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The lifetime risk for foot ulceration among dia-
betic patients is c. 15% [1]. Diabetic foot ulcers
affect quality of life, are associated with increased
morbidity and mortality, and have a major eco-
nomic impact [1]. Foot ulcers are frequently
complicated by infection, are responsible for more
prolonged hospitalisation than any other compli-
cation of diabetes, and are the most common
cause of lower-extremity amputations [1].
Methicillin-resistant Staphylococcus aureus
(MRSA) has emerged as a serious and common
problem in patients with diabetic foot ulcers [2,3].
Infection ⁄ colonisation with MRSA may result in
prolonged hospital stay and excessive direct
economic cost [1,3,4]. Previous studies have
examined the prevalence of MRSA in diabetic
foot wounds [2,4,5], but the present prospective
study examined the prevalence of MRSA among
patients with either infected or uninfected foot
ulcers, as well as the factors that predispose to
colonisation ⁄ infection with MRSA. The protocol
was approved by the Ethics Committee of the
hospital, and the study was performed in accord-
ance with the 1964 Declaration of Helsinki. In
addition, all subjects gave their written informed
consent.
In total, 84 consecutive patients (51 men and 33
women; 76 with type 2 and eight with type 1
diabetes) attending a specialised outpatient dia-
betic foot clinic on a weekly basis were included
in the study. The patients had a total of 91 foot
ulcers. The mean age was 60.1 (± 10.3) years, the
mean duration of diabetes was 10 (2–46) years,
and the mean 1c fraction of glucosylated haemo-
globin A (HBA1c) was 8.7% (± 2.5%).
Infection was diagnosed according to the cri-
teria proposed by the international consensus on
the diabetic foot [6]. Previous antibiotic treatment,
hospitalisations within the previous 3 months
and residence in nursing homes were recorded
systematically. None of the study patients had
infections at other body sites. Neuropathy was
diagnosed when vibration perception threshold
(VPT) at the tip of the big toe of the ulcerated foot,
as measured with a biothesiometer (Biomedical
Instrument Co., Newbury, OH, USA), was > 25 V
[7]. Peripheral vascular disease was diagnosed
when patients had an ankle–brachial pressure
index (ABI) < 0.9, as determined with a portable
Doppler machine (MD6 system; Hokanson Inc.,
Bellevue, WA, USA), or when they had a history
of intermittent claudication or of re-vascularisa-
tion procedures (percutaneous transluminal an-
gioplasty, by-pass graft) in the lower extremities.
Ulcers were classiﬁed as purely neuropathic
(VPT > 25 V and ABI > 0.9), as purely ischaemic
(ABI < 0.9 and VPT < 25 V), or as being of mixed
(neuroischaemic) aetiology (ABI < 0.9 and
VPT > 30 V) [7]. Ulcers were also classiﬁed
according to the Wagner classiﬁcation system [8].
Culture specimens were obtained from the base
of the ulcer with a sterile swab after debridement.
Specimens were placed in Transwab transport
medium (Medical Wire & Equipment, Corsham,
UK) and transported promptly to the microbiol-
ogy laboratory for aerobic and anaerobic culture
by conventional methods. Species identiﬁcation
was by Gram’s stain, catalase test, coagulase test,
the API Staph system (bioMe´rieux, Craponne,
France) for staphylococci, the API 20 Strep system
for enterococci and streptococci, and the API 32
GN system for Gram-negative bacteria. Suscepti-
bility of staphylococci to anti-staphylococcal pen-
icillins was tested with a 30-lg cefoxitin disk
according to NCCLS recommendations [9]. Sus-
ceptibility was conﬁrmed by detection of the mecA
gene by PCR as described previously [10]. Statis-
tical analysis was performed using an unpaired
Student’s t-test or a Mann–Whitney test, as
appropriate. Categorical data were compared
using a chi-square test.
In total, 45.2% of patients had purely neuro-
pathic ulcers, 6.0% had purely ischaemic ulcers,
and 48.8% had ulcers of mixed aetiology. The
distribution of the Wagner stages of the ulcers in
the study was as follows: stage 1, 14.3%; stage 2,
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47.5%; stage 3, 35.7%; and stage 4, 2.4%. In total,
156 microorganisms were isolated from the ulcers
of the patients. Among the Gram-positive bacteria
(n = 55), S. aureus predominated (n = 26; 47.3% of
Gram-positive isolates), and 12 (46.2%) of the S.
aureus isolates were MRSA. Seventeen coagulase-
negative Staphylococcus isolates were isolated. All
staphylococcal isolates that were methicillin-
resistant by the cefoxitin disk-diffusion test car-
ried the mecA gene, compared with none of the
methicillin-susceptible staphylococcal isolates.
Eleven Enterococcus isolates and one Streptococcus
agalactiae isolate were also found. Among 88
Gram-negative isolates, Enterobacteriaceae were
predominant (n = 70; 79.6%), and comprised 14
Klebsiella spp., 18 Escherichia coli, 16 Enterobacter
spp., seven Morganella morganii, ﬁve Serratia mar-
cescens, two Citrobacter spp. and eight Proteus spp.
Other Gram-negative isolates comprised Pseudo-
monas aeruginosa (n = 15; 17.1%) and Stenotropho-
monas maltophilia (n = 3; 3.4%). Thirteen
anaerobes were also isolated from the ulcers.
Of the 91 foot ulcers, 59 were infected and 32
were uninfected. Neither the prevalence of Gram-
positive and Gram-negative organisms nor the
prevalence of S. aureus differed signiﬁcantly
between patients with infected and uninfected
foot ulcers (p 0.37 and p 0.43, respectively). How-
ever, MRSA isolates were more common among
patients with infected foot ulcers than among
those with uninfected foot ulcers (61.1% vs.
12.5%, respectively; p 0.03; Table 1).
As in other studies [1,2,5], S. aureus was the
predominant Gram-positive pathogen, respon-
sible for infections of mild-to-moderate severity
in diabetic patients with foot ulcers. Although
the number of patients with MRSA was not
large in this study, the more frequent isolation
of MRSA in infected foot ulcers could indicate
that MRSA strains are more virulent than
methicillin-susceptible S. aureus (MSSA) strains.
Indeed, MRSA colonisation has been associated
previously with higher infection rates than has
MSSA colonisation [11,12], and some data sug-
gest that community-acquired MRSA may be
more virulent [13].
No signiﬁcant effect was found for factors that
have been shown previously to predispose to
colonisation with MRSA. None of the patients
was on renal replacement therapy, and none had
resided in a chronic-care facility. In total, 47.8% of
the cases with MRSA, and 52.6% of the cases
without MRSA, had been treated with antibiotics
in the 3-month period before the appearance of
the ulcer (p 0.29). Antibiotics commonly pre-
scribed were trimethoprim–sulphamethoxazole,
amoxycillin–clavulanic acid, second-generation
cephalosporins and clindamycin, all of which
were prescribed on an outpatient basis. The
proportion of patients with a history of recent
hospitalisation was similar in patients with and
without MRSA isolation (8.7% vs. 5.3%; p 0.26).
These ﬁndings contrast with previous reports of
an association between the prevalence of MRSA
and previous use of antibiotics [2,5]. Recent data
have, however, shown that the prevalence of
MRSA has risen in both the community [12] and
the hospitalised population [14–16]. Thus, the
absence of any association in the present study
between MRSA isolation and factors that predis-
pose to the appearance of MRSA in patients with
foot ulcers might reﬂect the high prevalence of
MRSA in the community [12].
Foot infection with MRSA has been associated
with longer hospital stay, greater costs and
greater mortality than infection with MSSA
[1,6,17]; thus, prevention of MRSA colonisa-
tion ⁄ infection is warranted [18]. Effective antibi-
otics, together with off-loading (reduction of the
pressure over the area of the ulcer), debridement
and adequate blood supply to the leg arteries, are
prerequisites for successful treatment of infected
diabetic foot wounds. Knowledge of the local
predominant pathogens helps in the selection of
empirical antibiotic treatment, and the frequent
isolation of MRSA from infected foot ulcers must
be taken into account when treatment with
antibiotics is prescribed.
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ABSTRACT
Group A streptococci (n = 123), isolated consecu-
tively from paediatric patients with pharyngitis
from Palermo, Italy, were analysed. The emm and
sof genes were sequenced, the presence of the
speA and speC genes was investigated, and the
macrolide resistance phenotypes and genotypes
were determined. A limited number of emm ⁄ sof
genotypes was found, and the most prevalent
types were different from those found in a
previous study from Rome. Macrolide resistance
was found in the most prevalent clones, suggest-
ing that the spread of mobile antibiotic resistance
genes among the ﬁttest clones in the community
was the main mechanism inﬂuencing macrolide
resistance rates in different emm types.
Keywords emm typing, group A streptococci, macro-
lide resistance, sof genes, spe genes, Streptococcus pyo-
genes
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Different rates of macrolide resistance have been
found in different clones of group A streptococci
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